跳至主要内容
临床试验/IRCT2016110627691N2
IRCT2016110627691N2已完成未知

The effectivness of cognitive behavioral therapy in combination with Pharmacotherapy on symptom control and quality of life in patients with schizophreneia

Tehran University of Medical Science ?Deputy of resaerch0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • patients with schizophrenia disorder according to DSM- IV -TR classificationand interview ; age between 20 to 50 ? at least 8 classes education; Patients will enrolled in the study only after obtaining informed consent; CBT will be the only psychosocial intervention which will be provided to these patients. Exclusion criteria:, with at least 8 classes education;Patients with any history of substance abuse ;.patients with any history of neurological or medical disorders

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Science ?Deputy of resaerch

相似试验